U.S. Communications Stock News

Earlier this month, Verizon Communications launched the kid-focused Gizmo Watch 4 in the US, adding advanced safety features, tight integration with the Verizon Family app, and aggressive promotions including free devices with new lines and waived activation fees through its new loyalty program. This push into family wearables, alongside enhanced rewards via Verizon Shine, highlights how Verizon is using ecosystem products and incentives to deepen household relationships without increasing...

In recent days, Energy Transfer LP announced a quarterly cash distribution of US$0.2111 per Series I Preferred Unit, payable on August 14, 2026 to unitholders of record as of August 4, 2026, while also updating the market on its large, fee-based midstream network and raised 2026 EBITDA guidance. Together with upbeat analyst views on its earnings outlook and industry support from growing data-center gas demand, these developments underscore how Energy Transfer’s contracted infrastructure...

GPGI (GPGI) is under increased legal and market scrutiny after multiple securities class action lawsuits alleged that the Husky Technologies acquisition was misrepresented, with claims of overstated value, unrealistic targets, and fee driven motivations. See our latest analysis for GPGI. At a recent share price of $14.07, GPGI has seen selling pressure build, with the 7 day share price return down 5.63% and the year to date share price return down 24.64%, even as the 3 year total shareholder...

Earlier in July 2026, a federal judge blocked Colorado’s plan to impose a very large price cut on Amgen’s arthritis drug Enbrel, halting one of the most aggressive state-level attempts to cap branded drug prices. This legal setback for Colorado reduces an important source of uncertainty around Enbrel’s pricing and puts a spotlight back on Amgen’s broader portfolio and policy exposure to future drug cost controls. We’ll now examine how the blocked Colorado Enbrel price cap reshapes Amgen’s...

Medpace Holdings (MEDP) opened Q2 2026 with total revenue of US$707.3 million and basic EPS of US$4.31, while trailing twelve month figures show revenue of US$2.8 billion and EPS of US$17.39 alongside 17.5% earnings growth and 21.2% annual earnings compounding over five years. The company has seen revenue move from US$2.2 billion and EPS of US$13.83 on a trailing basis in Q2 2025 to the latest trailing tallies, with earnings growth of 8.5% and revenue growth of 6.7% flagged in forecasts,...

Chefs' Warehouse (CHEF) is back in focus after a recent valuation check highlighted a rare split between models that estimate intrinsic value using discounted cash flows and more traditional, earnings-based yardsticks. See our latest analysis for Chefs' Warehouse. Chefs' Warehouse shares now trade at $94.46, with a 90 day share price return of 44.28% and a year to date share price return of 51.40%. The 5 year total shareholder return of 222.28% highlights longer term momentum that has...

Willdan Group (WLDN) has drawn fresh investor attention after being selected by Encina Wastewater Authority for a $31 million design-build contract to deliver a renewable cogeneration project using biogas for on-site electricity. See our latest analysis for Willdan Group. At a share price of $73.35, Willdan Group’s recent contract win comes after a period where momentum has cooled, with the share price down 10.86% over the past month and 31.23% year to date. However, the 3 year total...

Community Health Systems (CYH) opened Q2 2026 with total revenue of US$2.8 billion and basic EPS of US$0.52, setting a clear marker against a current share price of US$2.78. Over the past six quarters, the company has seen quarterly revenue move between US$2.8 billion and US$3.2 billion while basic EPS has ranged from a loss of US$3.68 per share on a trailing 12 month basis in early 2025 to a trailing 12 month EPS of US$1.87 in Q2 2026. For investors, the key question now is how durable those...

Earlier this week, Pfizer announced that the FDA accepted for Priority Review a supplemental application for TALZENNA plus XTANDI in men with HRR gene‑altered metastatic castration‑sensitive prostate cancer, supported by Phase 3 TALAPRO‑3 data showing a reduced risk of radiographic progression or death versus XTANDI alone. If approved, this would move the TALZENNA–XTANDI combination into an earlier stage of prostate cancer, potentially broadening its clinical role and reinforcing Pfizer’s...

Stewart Information Services (STC) has posted its Q2 2026 numbers with total revenue of US$899.2 million, basic EPS of about US$1.21 and net income of US$37.2 million. The trailing twelve months show revenue of US$3.3 billion, EPS of about US$4.60 and net income of US$134.7 million. The company has seen quarterly revenue move from US$722.2 million in Q2 2025 to US$899.2 million in Q2 2026, and basic EPS move from about US$1.13 to about US$1.21 over the same period. This sets up a results...

Marketing buzz, expansion, and an earnings catalyst for Chipotle Mexican Grill stock Chipotle Mexican Grill (CMG) heads into its July 29 earnings report with fresh attention driven by a $1 million burrito giveaway tied to a major soccer final and its first restaurant opening in Mexico. These events highlight how Chipotle Mexican Grill stock sits at the intersection of high visibility marketing and early stage international growth, elements many investors will weigh alongside upcoming revenue...

Ally Financial (ALLY) has put solid numbers on the board for Q2 2026, with revenue of US$2.1 billion, basic EPS of US$1.19 and net income of US$367 million, set against a trailing 12 month EPS of US$4.29 on revenue of US$7.9 billion and net income of US$1.33 billion, alongside reported earnings growth of 310.2% over the past year. Over recent quarters the company has seen revenue move from US$1.59 billion in Q1 2025 to US$2.13 billion in Q2 2026, while quarterly basic EPS shifted from a loss...

Bristol Gate Capital Partners recently added Howmet Aerospace (HWM) to its Q2 2026 US Equity Strategy, highlighting management’s capital allocation and focus on projects that build on the company’s position in aerospace, defense, and industrial markets. See our latest analysis for Howmet Aerospace. Howmet Aerospace’s recent 1 day share price return of 2.28% and 7 day share price return of 5.86% come on top of a 90 day share price return of 18.42% and a 1 year total shareholder return of...

ASML Holding Stock Snapshot ASML Holding (NasdaqGS:ASML) remains a focal point for chip equipment investors. The stock recently closed at US$1,803 and carries a market value of about US$689.9b in the semiconductor equipment and services space. See our latest analysis for ASML Holding. Recent trading shows steady upward momentum in ASML Holding’s share price, with a 90 day share price return of 23.69% and a 1 year total shareholder return of 150.32%, pointing to strong recent sentiment around...

Interactive Brokers Group (IBKR) has just posted Q2 2026 results with revenue of US$1.9b, basic EPS of US$0.70 and net income of US$312 million, setting the tone for how investors assess the latest quarter. Over recent periods the company has seen quarterly revenue move from US$1.53b in Q2 2025 to US$1.88b in Q2 2026, while basic EPS has tracked from US$0.51 to US$0.70 over the same quarters, providing a clearer view of how the income statement is scaling. With trailing twelve month net...

United Parcel Service has climbed 18.9% over the past year but is still down 27.9% over three years, while valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both point to the stock trading below what its cash flows may justify. That sets up a clear tension between a recovering share price and indicators that still suggest potential undervaluation. The share price decline of 27.9% over three years means long-term holders are still under water,...

Viking Therapeutics (NasdaqCM:VKTX) has appointed healthcare executive Dorothy Gemmell to its Board of Directors. Gemmell brings leadership experience across healthcare, digital health, and commercial execution for high growth companies. The board change is viewed as a material governance development for the company as it advances its pipeline. Viking Therapeutics enters this board transition with its stock at $35.39 and very large 3 year and 5 year share price gains, alongside a 5.6%...

In recent days, Coherent has drawn attention after issuing fiscal Q4 2026 guidance above analyst expectations and preparing to report its June-quarter results, with the company highlighting strong AI-related semiconductor and data center optics demand supported by long-term customer commitments and a record backlog. What stands out is how this AI infrastructure momentum coincides with increasingly positive analyst sentiment and a Zacks Rank #2 rating, positioning the upcoming August 12...

Symbotic (SYM) is back in focus after expectations emerged for a very large year over year earnings increase this quarter, drawing attention to how the warehouse automation company’s stock trades ahead of the report. See our latest analysis for Symbotic. At a share price of $42.46, Symbotic’s recent 30 day share price return of 5.62% contrasts with a 90 day share price drop of 32.07%. The 5 year total shareholder return of 331.50% highlights how long term holders have had a very different...

Oceaneering International (OII) opened Q2 2026 with total revenue of US$768.2 million and basic EPS of US$0.65, setting the tone for a results set that puts both growth and profitability under the spotlight for investors. The company reported revenue of US$698.2 million in Q2 2025 and US$768.2 million in Q2 2026, while basic EPS moved from US$0.54 to US$0.65 over the same period, against a trailing net margin profile that now sits in the low double digits and keeps the focus on how durable...

Cerebras Systems stock has fallen about 29.3% year to date, even as recent news around AI infrastructure expansion and partnerships has kept the story in focus. This leaves investors weighing whether the current price still reflects a fair trade off between growth expectations and risk. With the broader valuation checks showing a mixed picture rather than a clear bargain, the recent rebound in the share price adds another layer to that debate. Year to date, Cerebras Systems is down 29.3%...

Raymond James Financial (RJF) has reported Q3 2026 revenue of US$3.95 billion and basic EPS of US$3.07, with trailing twelve month EPS at US$11.70 on revenue of US$15.25 billion, setting a clear benchmark for its latest quarter. The company has seen quarterly revenue move from US$3.40 billion in Q2 2025 to US$3.95 billion in Q3 2026, while quarterly EPS shifted from US$2.41 to US$3.07 over the same period, giving investors a concrete view of its recent earnings run rate and how it feeds into...

WEX (WEX) opened Q2 2026 with total revenue of $753.5 million, basic EPS of $3.13 and quarterly net income of $108.5 million, setting the tone for its latest earnings update. The company has seen revenue move from $659.6 million and EPS of $1.99 in Q2 2025 to $753.5 million and EPS of $3.13 in Q2 2026, alongside trailing 12 month EPS of $10.17 on revenue of $2.8 billion. This frames the recent quarter against a fuller earnings backdrop. With trailing net profit margins running ahead of last...

Kaiser Aluminum (KALU) opened Q2 2026 with revenue of US$1.3 billion, basic EPS of US$5.92 and net income of US$96.8 million, framing a quarter where profitability stayed firmly in focus. The company has seen revenue move from US$823.1 million and EPS of US$1.44 in Q2 2025 to US$1.3 billion and EPS of US$5.92 in Q2 2026. Trailing 12 month EPS reached US$13.97 on revenue of US$4.1 billion as margins lifted from a 1.8% to 5.5% net profit level over the past year. For investors, these results...